GlassScriptPhysician profile
Robyn M Johnson
NPI 1265892475
$3,629.40
in general payments reported to CMS, 2019-2025
30 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.90 · 2022: $585 · 2023: $951 · 2024: $947 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $668.92 | 2021-2025 | |
| Abbvie INC. | $574.79 | 2021-2025 | |
| Amgen INC. | $401.56 | 2022-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $322.45 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $312.52 | 2022-2024 | Jardiance, Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $202.74 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $164.82 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Phathom Pharmaceuticals, INC. | $94.85 | 2023-2025 | Voquezna |
| Abbott Laboratories | $88.49 | 2022-2025 | Freestyle Libre 3, Freestyle Libre, Freestyle Libre 2 |
| Dynavax Technologies Corporation | $87.59 | 2024-2025 | Heplisav-B |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.69 | 2023-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $65.67 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $58.26 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $56.61 | 2022 | |
| Myriad Women'S Health, INC. | $52.68 | 2023 | Myrisk |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $52.23 | 2022-2023 | |
| Exeltis, USA INC. | $51.75 | 2023-2024 | Slynd |
| Sanofi Pasteur INC. | $51.32 | 2023-2025 | |
| Baxter Healthcare | $41.30 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.46 | 2022-2025 | Jardiance |
| Biohaven Pharmaceuticals, INC. | $26.42 | 2021 | |
| Dexcom, INC. | $17.78 | 2025 | Dexcom G6 Transmitter |
| Ironwood Pharmaceuticals, INC | $17.50 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $17.37 | 2021 | |
| Genentech USA, INC. | $17.24 | 2021 | |
| Hologic Sales and Service, LLC | $16.52 | 2025 | Aptima |
| Biogen, INC. | $16.34 | 2025 | Skyclarys |
| Supernus Pharmaceuticals, INC. | $15.27 | 2023 | |
| Organon LLC | $15.12 | 2025 | Nexplanon |
| Mylan Specialty L.P. | $14.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.